2-73385903-TGGAGGAGGAGGAGGAGGAGGAGGAGGA-TGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGA

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP3BP6_Very_Strong

The NM_001378454.1(ALMS1):​c.54_74dupGGAGGAGGAGGAGGAGGAGGA​(p.Glu19_Glu25dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. E25E) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000084 ( 0 hom., cov: 0)
Exomes 𝑓: 0.000074 ( 0 hom. )

Consequence

ALMS1
NM_001378454.1 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:2

Conservation

PhyloP100: 0.369

Publications

7 publications found
Variant links:
Genes affected
ALMS1 (HGNC:428): (ALMS1 centrosome and basal body associated protein) This gene encodes a protein containing a large tandem-repeat domain as well as additional low complexity regions. The encoded protein functions in microtubule organization, particularly in the formation and maintanance of cilia. Mutations in this gene cause Alstrom syndrome. There is a pseudogene for this gene located adjacent in the same region of chromosome 2. Alternative splice variants have been described but their full length nature has not been determined. [provided by RefSeq, Apr 2014]
ALMS1 Gene-Disease associations (from GenCC):
  • Alstrom syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, G2P, Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_001378454.1
BP6
Variant 2-73385903-T-TGGAGGAGGAGGAGGAGGAGGA is Benign according to our data. Variant chr2-73385903-T-TGGAGGAGGAGGAGGAGGAGGA is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 241005.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALMS1NM_001378454.1 linkc.54_74dupGGAGGAGGAGGAGGAGGAGGA p.Glu19_Glu25dup disruptive_inframe_insertion Exon 1 of 23 ENST00000613296.6 NP_001365383.1
ALMS1NM_015120.4 linkc.54_74dupGGAGGAGGAGGAGGAGGAGGA p.Glu19_Glu25dup disruptive_inframe_insertion Exon 1 of 23 NP_055935.4 Q8TCU4
LOC105374804XR_007087045.1 linkn.-243_-223dupTCCTCCTCCTCCTCCTCCTCC upstream_gene_variant
LOC105374804XR_007087053.1 linkn.-243_-223dupTCCTCCTCCTCCTCCTCCTCC upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALMS1ENST00000613296.6 linkc.54_74dupGGAGGAGGAGGAGGAGGAGGA p.Glu19_Glu25dup disruptive_inframe_insertion Exon 1 of 23 1 NM_001378454.1 ENSP00000482968.1 Q8TCU4-1

Frequencies

GnomAD3 genomes
AF:
0.0000836
AC:
12
AN:
143532
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0000251
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000681
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000870
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000213
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000622
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000735
AC:
41
AN:
557726
Hom.:
0
Cov.:
0
AF XY:
0.0000638
AC XY:
19
AN XY:
297820
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
15796
American (AMR)
AF:
0.00
AC:
0
AN:
31236
Ashkenazi Jewish (ASJ)
AF:
0.0000567
AC:
1
AN:
17646
East Asian (EAS)
AF:
0.000294
AC:
9
AN:
30664
South Asian (SAS)
AF:
0.0000358
AC:
2
AN:
55942
European-Finnish (FIN)
AF:
0.000110
AC:
4
AN:
36320
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2422
European-Non Finnish (NFE)
AF:
0.0000711
AC:
24
AN:
337580
Other (OTH)
AF:
0.0000332
AC:
1
AN:
30120
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.319
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000835
AC:
12
AN:
143636
Hom.:
0
Cov.:
0
AF XY:
0.0000718
AC XY:
5
AN XY:
69662
show subpopulations
African (AFR)
AF:
0.0000250
AC:
1
AN:
39970
American (AMR)
AF:
0.0000680
AC:
1
AN:
14700
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3322
East Asian (EAS)
AF:
0.000873
AC:
4
AN:
4584
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4264
European-Finnish (FIN)
AF:
0.000213
AC:
2
AN:
9398
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
266
European-Non Finnish (NFE)
AF:
0.0000622
AC:
4
AN:
64334
Other (OTH)
AF:
0.00
AC:
0
AN:
1972
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.400
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age

ClinVar

Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Alstrom syndrome Uncertain:1
Nov 01, 2019
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:1
Nov 07, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: ALMS1 c.57_74dup18 (p.Glu23_Glu28dup) results in an in-frame duplication that is predicted to duplicate 6 amino acids into the ALMS repeat region/Glu repetitive region (Glu13_Glu28) of the encoded protein. The variant was absent in 83366 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.57_74dup18 in individuals affected with Alstrom Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. Other duplication variants located in this Glu repetitive region (examples: c.54_74dup21/p.Glu22_Glu28dup, c.60_74dup15/p.Glu24_Glu28dup) have been classified as likely benign by our laboratory. Furthermore, there are no reports of other variants in this Glu repetitive region in the HGMD database. One submitter has cited clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as benign. Based on the evidence outlined above, the variant was classified as as likely benign. -

Cardiovascular phenotype Benign:1
Aug 18, 2021
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.37
Mutation Taster
=78/22
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55889738; hg19: chr2-73613031; API